We work with a range of partners across a variety of sectors, all with the aim of further supporting our patients’ needs.
Cycle and Catalent
Cycle and Catalent, Inc. (NYSE: CTLT) have partnered to develop 4 products that will each use Catalent’s Zydis® oral disintegrating tablet (ODT) and Zydis Ultra® technologies.
Zydis® and Zydis Ultra® are registered trademarks of R.P. Scherer Technologies, Inc., a wholly owned subsidiary of Catalent, Inc.